Orakl Oncology is a techbio platform that operates in the oncology sector. The company's offerings include tumor models that replicate drug responses, integrated with clinical and omics data, and analysis to derive insights from experimental data. Orakl Oncology serves the oncology industry, partnering with various players to advance medicine.